BRKR
Price
$56.82
Change
+$0.63 (+1.12%)
Updated
Oct 14, 11:04 AM (EDT)
Capitalization
9.64B
15 days until earnings call
Intraday BUY SELL Signals
WAT
Price
$438.36
Change
+$9.19 (+2.14%)
Updated
Oct 14, 11:22 AM (EDT)
Capitalization
43.49B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BRKR vs WAT

BRKR vs WAT Comparison Chart in %
View a ticker or compare two or three
VS
BRKR vs. WAT commentary
Oct 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKR is a Hold and WAT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BRKR with price predictions
Oct 13, 2026

BRKR in -4.50% downward trend, sliding for three consecutive days on October 13, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BRKR declined for three days, in 234 of 317 cases, the price declined further within the following month. The odds of a continued downward trend are 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRKR as a result. In 67 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 71%.

The Moving Average Convergence Divergence Histogram (MACD) for BRKR turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 27 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 63%.

BRKR moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The 10-day moving average for BRKR crossed bullishly above the 50-day moving average on September 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +3.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where BRKR advanced for three days, in 201 of 290 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

BRKR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. BRKR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.049) is normal, around the industry mean (10.930). P/E Ratio (74.885) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (1.070) is also within normal values, averaging (11.052). Dividend Yield (0.003) settles around the average of (0.002) among similar stocks. P/S Ratio (2.634) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRKR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for WAT with price predictions
Oct 13, 2026

Momentum Indicator for WAT turns negative, indicating new downward trend

WAT saw its Momentum Indicator move below the 0 level on October 12, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned negative. In 68 of the 93 cases, the stock moved further down in the following days. The odds of a decline are at 73%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for WAT moved out of overbought territory on September 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 similar instances where the indicator moved out of overbought territory. In 23 of the 33 cases, the stock moved lower in the following days. This puts the odds of a move lower at 70%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 70 cases where WAT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 64%.

The Moving Average Convergence Divergence Histogram (MACD) for WAT turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 28 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WAT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 63%.

WAT broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +2.24% 3-day Advance, the price is estimated to grow further. Considering data from situations where WAT advanced for three days, in 173 of 277 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 118 of 207 cases where WAT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 3 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 21 (best 1 - 100 worst), indicating outstanding price growth. WAT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.864) is normal, around the industry mean (72.578). P/E Ratio (112.137) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (1.649) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.001) among similar stocks. P/S Ratio (6.752) is also within normal values, averaging (9.775).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 91 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WAT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

FUNDAMENTALS RATINGS
BRKR vs WAT: Fundamental Ratings
BRKR
WAT
OUTLOOK RATING
1..100
7582
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9289
PRICE GROWTH RATING
1..100
3921
P/E GROWTH RATING
1..100
53
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BRKR's Valuation (59) in the Medical Specialties industry is in the same range as WAT (74). This means that BRKR’s stock grew similarly to WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as BRKR (100). This means that WAT’s stock grew similarly to BRKR’s over the last 12 months.

WAT's SMR Rating (89) in the Medical Specialties industry is in the same range as BRKR (92). This means that WAT’s stock grew similarly to BRKR’s over the last 12 months.

WAT's Price Growth Rating (21) in the Medical Specialties industry is in the same range as BRKR (39). This means that WAT’s stock grew similarly to BRKR’s over the last 12 months.

WAT's P/E Growth Rating (3) in the Medical Specialties industry is in the same range as BRKR (5). This means that WAT’s stock grew similarly to BRKR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BRKRWAT
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
64%
Momentum
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
73%
MACD
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
69%
Bullish Trend 16 days ago
62%
Declines
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
63%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
62%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
57%
COMPARISON
Comparison
Oct 14, 2026
Stock price -- (BRKR: $56.19 vs. WAT: $429.17)
Brand notoriety: BRKR and WAT are both not notable
BRKR represents the Medical/Nursing Services, while WAT is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BRKR: 90% vs. WAT: 141%
Market capitalization -- BRKR: $9.64B vs. WAT: $43.49B
BRKR [@Medical/Nursing Services] is valued at $9.64B. WAT’s [@Medical Specialties] market capitalization is $43.49B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.73B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The average market capitalization across the [@Medical/Nursing Services] industry is $5.59B. The average market capitalization across the [@Medical Specialties] industry is $20.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BRKR’s FA Score shows that 1 FA rating(s) are green while WAT’s FA Score has 2 green FA rating(s).

  • BRKR’s FA Score: 1 green, 4 red.
  • WAT’s FA Score: 2 green, 3 red.
According to our system of comparison, BRKR is a better buy in the long-term than WAT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BRKR’s TA Score shows that 4 TA indicator(s) are bullish while WAT’s TA Score has 2 bullish TA indicator(s).

  • BRKR’s TA Score: 4 bullish, 4 bearish.
  • WAT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, BRKR is a better buy in the short-term than WAT.

Price Growth

BRKR (@Medical/Nursing Services) experienced а -7.12% price change this week, while WAT (@Medical Specialties) price change was -1.66% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -3.54%. For the same industry, the average monthly price growth was -6.26%, and the average quarterly price growth was -14.18%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.55%. For the same industry, the average monthly price growth was +0.69%, and the average quarterly price growth was +36.12%.

Reported Earning Dates

BRKR is expected to report earnings on Oct 29, 2026.

WAT is expected to report earnings on Nov 03, 2026.

Industries' Descriptions

@Medical/Nursing Services (-3.54% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Medical Specialties (-2.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

View a ticker or compare two or three
BRKR
Daily Signal:
Gain/Loss:
WAT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YETI39.340.33
+0.85%
YETI Holdings
SQM62.830.36
+0.58%
Sociedad Quimica y Minera de Chile SA
BCAL21.41-0.08
-0.37%
California BanCorp
MGRX0.37-0.01
-3.08%
Mangoceuticals Inc
CRBU0.47-0.03
-5.41%
Caribou Biosciences

BRKR and

Correlation & Price change

A.I.dvisor indicates that over the last year, BRKR has been closely correlated with BRKRP. These tickers have moved in lockstep 91% of the time. This A.I.-generated data suggests there is a high statistical probability that if BRKR jumps, then BRKRP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BRKR
1D Price
Change %
BRKR100%
-0.11%
BRKRP - BRKR
91%
Closely correlated
-0.19%
A - BRKR
78%
Closely correlated
+0.16%
MTD - BRKR
75%
Closely correlated
+2.24%
WAT - BRKR
68%
Closely correlated
-0.68%
RVTY - BRKR
68%
Closely correlated
-0.34%
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been loosely correlated with A. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if WAT jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
-0.68%
A - WAT
65%
Loosely correlated
+0.16%
RVTY - WAT
60%
Loosely correlated
-0.34%
BRKR - WAT
58%
Loosely correlated
-0.11%
CRL - WAT
57%
Loosely correlated
-0.94%
TMO - WAT
56%
Loosely correlated
+0.12%
More